Import dependence on key pharma ingredients may reduce by half, DrugsControl Media Services

News Detail

Import dependence on key pharma ingredients may reduce by half (14-11-2024)

New Delhi, 14 Nov 2024: India is seeking to bolster local production and cut its import dependence by half for critical pharmaceutical ingredients, especially from China, in the wake of the inauguration of two greenfield plants.

The two plants were inaugurated la......
View Details

Source : Business Standard

New Delhi 14 Nov 2024: India is seeking to bolster local production and cut its import dependence by half for critical pharmaceutical ingredients especially from China in the wake of the inauguration of two greenfield plants. The two plants were inaugurated last month under the Production Linked Incentive (PLI) scheme for bulk drugs to reduce import dependence on key starting materials (KSM) and active pharmaceutical ingredients (API). They have been earmarked to manufacture Penicillin G 6-APA (6-Aminopenicillanic acid) and Clavulanic Acid important molecules used in several common antibiotics whose production was stopped in the country for over two decades. Anil Matai director general Organisation of Pharmaceutical Producers of India (OPPI) stated that Penicillin G and Clavulanic Acid have historically been sourced primarily from China leaving the Indian pharmaceutical sector vulnerable to external supply disruptions. With the inauguration of these facilities the

News Detail

Related News